Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
BioMarin
Sort By
Newest First
1 / 1
Drug Approval
BioMarin Going for 2020 Approval of its Hemophilia A Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M08-19-NI-026
Aug 22, 2019
Positive Opinion
BioMarin Receives Positive CHMP Opinion in Europe for Palynziq® (pegvaliase Injection) for Treatment of Patients with Phenylketonuria (PKU) Aged 16 and Older
BioMarin
PR-M03-19-NI-008
Mar 04, 2019
Clinical Trials
BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
BioMarin
PR-M06-18-NI-059
Jun 18, 2018
Hemophilia
Results of New Gene Therapy Revealed at Hemophilia Meeting
Nice Insight
PAO-M12-17-NI-017
Dec 12, 2017
FDA
BioMarin Highlights Advanced Genetic Disease Therapy Pipeline
Nice Insight
PAO-M10-17-NI-035
Oct 24, 2017
1 / 1
